Immature patients in a mature system: Regional analysis of Florida's pediatric trauma system

Christopher W Snyder1, Nicole M Chandler, Cristen N Litz

  • 1From the Division of Pediatric Surgery (C.W.S., N.M.C., C.N.L., P.D.D.), Johns Hopkins All Children's Hospital, St. Petersburg, Florida; Division of Trauma and Acute Care Surgery (C.W.S., D.J.C.), University of South Florida, Tampa, Florida; and College of Public Health (E.E.P.), University of South Florida, Tampa, Florida.

Insights

Florida

Area of Science:

  • Pediatric trauma care
  • Health systems research
  • Public health policy

Background:

  • Florida's trauma system is organized into seven regions.
  • Two regions lack dedicated pediatric trauma centers, necessitating out-of-region transfers for injured children.
  • This study evaluates the effectiveness and efficiency of the current regionalization strategy.

Purpose of the Study:

  • To assess the effectiveness of Florida's regionalized pediatric trauma system.
  • To identify variations in care and outcomes across different regions.
  • To evaluate the efficiency of the current trauma system, particularly concerning out-of-region transfers.

Main Methods:

  • Analysis of the Florida Agency for Health Care Administration database (2009-2014).
  • Inclusion of trauma patients aged 15 or younger.
  • Identification of undertriage and potentially avoidable out-of-region treatment using ICD-9 Injury Severity Score and treatment details. Regression models adjusted for covariates.

Main Results:

  • Overall mortality was 1% among 34,816 pediatric trauma patients.
  • Risk-adjusted outcomes were similar across regions, but undertriage rates varied (0.4%-4.7%), highest in regions without a pediatric trauma center.
  • Out-of-region treatment increased hospital charges and length of stay; unexplained variations in potentially avoidable out-of-region treatment were noted in regions lacking a pediatric trauma center.

Conclusions:

  • Florida's pediatric trauma system demonstrates effectiveness with low undertriage and acceptable outcomes.
  • Out-of-region treatment, though sometimes necessary, adds burden to patients and facilities.
  • System efficiencies can be improved, particularly in reducing unexplained variations in potentially avoidable out-of-region transfers.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
747
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392